Long-term Multiple Center Experience in Treating Plaque Psoriasis with Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Clinical trial data regarding the efficacy of halobetasol propionate 0.01% and tazarotene 0.045% lotion (HP/TAZ), a super-potent corticosteroid and retinoid fixed combination topical medication, has been promising. Despite this, real-world experience of HP/TAZ in a community setting is limited.
创建时间：
2023-01-03
